Try our Advanced Search for more refined results
October 16, 2018
In re Keryx Biopharmaceuticals, Inc.
Case Number:
1:18-cv-01589
Court:
Nature of Suit:
Multi Party Litigation:
Class Action
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
April 16, 2020
Keryx Proxy Action Ignored 'Tailored Warning,' Judge Says
A Delaware federal judge on Wednesday dismissed a shareholder's proposed class action alleging Keryx Biopharmaceuticals Inc. misled the public in the lead-up to a December 2018 shareholder vote on the company's acquisition by Akebia Therapeutics Inc.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login